Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04103424 · ClinicalTrials.gov registry record · NA
Mitochondrial Remodeling After Exercise
A NA study of Insulin Resistance and Overweight and Obesity, sponsored by Oregon State University.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT04103424: Completed NA study of Insulin Resistance and Overweight and Obesity, sponsored by Oregon State University.
NCT04103424 is a NA study of Insulin Resistance and Overweight and Obesity that has completed, run by Oregon State University. The registered enrollment target is 31 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04103424, a NA study of Insulin Resistance and Overweight and Obesity, has completed, sponsored by Oregon State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
Regulation of mitochondrial health in overweight and obese individuals may be impaired. The purpose of this study is to identify impairments in regulation of mitochondrial health within skeletal muscle and to determine if short-term exercise training (2-weeks) can reverse such impairments. The investigator's hypothesis is that pathways that serve to degrade poorly functioning mitochondria in overweight and obese individuals are down-regulated, but that short-term exercise training can restore these pathways to improve skeletal muscle mitochondrial function.
Primary Outcome
Skeletal muscle mitochondrial protein degradation peptide products after 2-weeks of exercise training compared with before training.
Conditions Studied
Interventions
- BEHAVIORAL Short-term Exercise Training
Study Locations (1)
Oregon
- Oregon State University - Corvallis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2019-08-23 |
| Est. Completion | 2022-12-03 |
| Phase | NA |
What the finished NCT04103424 record still lists
NCT04103424 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (87% lower).
The record links to 5 conditions, with Insulin Resistance appearing as the primary indexed condition, and to 1 intervention - of which Short-term Exercise Training is the first listed.
NCT04103424 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT04103424 about?
NCT04103424 is a clinical study titled "Mitochondrial Remodeling After Exercise". Regulation of mitochondrial health in overweight and obese individuals may be impaired. The purpose of this study is to identify impairments in regulation of mitochondrial health within skeletal muscle and to determine if short-term exercise training (2-weeks) can reverse such impairments. The inves...
What is the current status of trial NCT04103424?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2019-08-23. Estimated completion is 2022-12-03.
What conditions does trial NCT04103424 study?
This clinical trial studies the following conditions: Insulin Resistance, Overweight and Obesity, Metabolic Disease, Sedentary Lifestyle, Mitochondrial Metabolism.
What interventions are being tested in trial NCT04103424?
The interventions under investigation include: Short-term Exercise Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT04103424?
This trial is sponsored by Oregon State University, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04103424 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04103424's enrollment target sits among peer trials
31 87th of 120 higher than 33 of 120 other Insulin Resistance trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insulin Resistance trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Small Extracellular Vesicles and Insulin Action
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
New Mechanisms of Obesity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI